A service provided by the BC Centre for Disease Control



How has the threat of multi-drug resistant gonorrhea changed chlamydia treatment recommendations?

November 28, 2012 by Richard Lester, Medical Head, STI/HIV Services (Clinical Prevention Services), BCCDC

The global threat of multi-drug resistant Neisseria gonorrhea has led to recent changes in treatment recommendations. Intramuscular ceftriaxone (250mg single dose IM) is now preferred over oral cefixime to treat all proven or suspected gonococcal infections in gay, bisexual and other men who have sex with men (MSM), and for pharyngeal gonorrhea irrespective of the…

Learn more